Efficacy of a prolonged stability melphalan formulation for intra-arterial treatment of retinoblastoma.

Published in: Journal of neurointerventional surgery (2023)

Evomela has non-inferior safety and efficacy relative to SFM when used for the treatment of retinoblastoma by selective ophthalmic artery infusion.

Keyphrases